Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
HRTX | HERON THERAPEUTICS, INC. /DE/ | EVP, Chief Development Officer | $1.07M | Oct 19, 2024 | ||
XAIR | Beyond Air, Inc. | Director | Nov 22, 2024 | |||
TRVI | Trevi Therapeutics, Inc. | Chief Development Officer | Jun 29, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|